# Urothelial Carcinoma of the Bladder Following BK Virus Infection in a Pediatric Kidney Transplant Recipient

**Authors:** Martina Ichas, Lise Allard, Luke Harper, Mokrane Yacoub, Iona Madden, Cécile Vérité, Astrid Godron‐Dubrasquet, Jérôme Harambat

PMC · DOI: 10.1111/petr.70303 · Pediatric Transplantation · 2026-03-19

## TL;DR

A child who received a kidney transplant developed bladder cancer years later, possibly linked to a BK virus infection.

## Contribution

This case suggests a potential role of BK virus in bladder cancer development in immunosuppressed transplant recipients.

## Key findings

- A pediatric kidney transplant recipient developed high-grade urothelial bladder carcinoma four years post-transplant.
- The tumor showed SV40 positivity, indicating a possible BK virus-induced neoplasia.
- The patient remained disease-free for seven years after surgery without additional treatment.

## Abstract

Urothelial bladder carcinoma is extremely rare in children and its association with BK virus infection remains unclear.

We describe the case of an 11‐year‐old girl who developed a urothelial carcinoma of the bladder four years after receiving her first kidney transplant. Kidney failure was secondary to nephronophthisis (NPHP6 variant), diagnosed in the neonatal period and associated with Leber congenital amaurosis and intellectual disability. She underwent peritoneal dialysis for four years before kidney transplantation at 6.5 years of age. Five months post‐transplant, she developed BK virus‐associated nephropathy, leading to chronic allograft dysfunction. Four years later, a routine ultrasound revealed an asymptomatic bladder mass without evidence of extension. The lesion was resected endoscopically and later managed with partial cystectomy.

Histopathologic analysis confirmed a high‐grade invasive urothelial carcinoma (pT2). Immunohistochemistry showed SV40 positivity, consistent with BK virus‐induced neoplasia, while non‐tumoral cells were negative. BK viremia had been undetectable one year prior to diagnosis. The patient remained disease‐free for seven years following surgery, without adjuvant therapy.

The involvement of BK virus in the development of bladder cancer has not yet been clarified. This case supports a possible role of BK virus in urothelial tumorigenesis, particularly in immunosuppressed transplant recipients.

## Linked entities

- **Diseases:** nephronophthisis (MONDO:0019005), Leber congenital amaurosis (MONDO:0018998), intellectual disability (MONDO:0001071), urothelial carcinoma (MONDO:0040679)

## Full-text entities

- **Genes:** KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, GATA3 (GATA binding protein 3) [NCBI Gene 2625] {aka HDR, HDRS}, RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, CEP290 (centrosomal protein 290) [NCBI Gene 80184] {aka 3H11Ag, BBS14, CT87, JBTS5, LCA10, MKS4}, LINC01194 (long intergenic non-protein coding RNA 1194) [NCBI Gene 404663] {aka CT49, TAG}
- **Diseases:** BK Virus Infection (MESH:D014777), acute kidney injury (MESH:D058186), ureteral stenosis (MESH:D014515), Leber congenital amaurosis (MESH:D057130), cancer (MESH:D009369), nephritis (MESH:D009393), infectious colitis (MESH:D003141), bladder (MESH:D001745), collecting duct carcinoma (MESH:D002292), carcinogenic (MESH:D011230), chronic allograft nephropathy (MESH:D051436), tubulointerstitial nephritis (MESH:D009395), allograft dysfunction (MESH:D000092122), nephronophthisis (MESH:C537699), BK polyomavirus infection (MESH:D027601), Kidney failure (MESH:D051437), hemorrhagic cystitis (MESH:D006470), infection (MESH:D007239), urological malignancies (MESH:D014571), Clostridium difficile (MESH:D003015), nephropathy (MESH:D007674), Urothelial Carcinoma (MESH:D014523), intellectual disability (MESH:D008607), toxicity (MESH:D064420), Urothelial Carcinoma of the Bladder (MESH:D001749), BK viremia (MESH:D014766), end-stage kidney disease (MESH:D007676), prostatic, ureteral, and renal tumors (MESH:D011472), CMV (MESH:D003586)
- **Chemicals:** mycophenolate mofetil (MESH:D009173), tacrolimus (MESH:D016559), everolimus (MESH:D000068338), aromatic amine (-), leflunomide (MESH:D000077339), prednisolone (MESH:D011239)
- **Species:** SV40 [taxon 10633], Polyomavirus sp. (species) [taxon 36362], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Kayvirus kay (species) [taxon 221915], Human papillomavirus (species) [taxon 10566], Norovirus (genus) [taxon 142786], Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097], Salmonella (genus) [taxon 590], Betapolyomavirus hominis (species) [taxon 1891762]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13002325/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13002325/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC13002325/full.md

---
Source: https://tomesphere.com/paper/PMC13002325